nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—EBP—uterine cervix—vaginal cancer	0.059	0.059	CbGeAlD
Haloperidol—EBP—uterus—vaginal cancer	0.0492	0.0492	CbGeAlD
Haloperidol—EBP—female reproductive system—vaginal cancer	0.0442	0.0442	CbGeAlD
Haloperidol—CBR1—uterine cervix—vaginal cancer	0.0269	0.0269	CbGeAlD
Haloperidol—CBR1—urethra—vaginal cancer	0.0247	0.0247	CbGeAlD
Haloperidol—CBR1—endometrium—vaginal cancer	0.0243	0.0243	CbGeAlD
Haloperidol—CBR1—mammalian vulva—vaginal cancer	0.0236	0.0236	CbGeAlD
Haloperidol—CBR1—uterus—vaginal cancer	0.0224	0.0224	CbGeAlD
Haloperidol—H1F0—uterine cervix—vaginal cancer	0.0221	0.0221	CbGeAlD
Haloperidol—H1F0—urethra—vaginal cancer	0.0203	0.0203	CbGeAlD
Haloperidol—CBR1—female reproductive system—vaginal cancer	0.0202	0.0202	CbGeAlD
Haloperidol—H1F0—endometrium—vaginal cancer	0.02	0.02	CbGeAlD
Haloperidol—H1F0—mammalian vulva—vaginal cancer	0.0193	0.0193	CbGeAlD
Haloperidol—H1F0—uterus—vaginal cancer	0.0184	0.0184	CbGeAlD
Haloperidol—CBR1—female gonad—vaginal cancer	0.0184	0.0184	CbGeAlD
Haloperidol—CBR1—vagina—vaginal cancer	0.0182	0.0182	CbGeAlD
Haloperidol—H1F0—female reproductive system—vaginal cancer	0.0165	0.0165	CbGeAlD
Haloperidol—SIGMAR1—uterine cervix—vaginal cancer	0.0159	0.0159	CbGeAlD
Haloperidol—HTR2B—uterine cervix—vaginal cancer	0.0159	0.0159	CbGeAlD
Haloperidol—H1F0—female gonad—vaginal cancer	0.015	0.015	CbGeAlD
Haloperidol—H1F0—vagina—vaginal cancer	0.0149	0.0149	CbGeAlD
Haloperidol—SIGMAR1—urethra—vaginal cancer	0.0146	0.0146	CbGeAlD
Haloperidol—SIGMAR1—endometrium—vaginal cancer	0.0144	0.0144	CbGeAlD
Haloperidol—HTR2B—endometrium—vaginal cancer	0.0144	0.0144	CbGeAlD
Haloperidol—SIGMAR1—mammalian vulva—vaginal cancer	0.0139	0.0139	CbGeAlD
Haloperidol—SIGMAR1—uterus—vaginal cancer	0.0133	0.0133	CbGeAlD
Haloperidol—HTR2B—uterus—vaginal cancer	0.0132	0.0132	CbGeAlD
Haloperidol—HTR1B—female reproductive system—vaginal cancer	0.0132	0.0132	CbGeAlD
Haloperidol—HTR1D—female reproductive system—vaginal cancer	0.0128	0.0128	CbGeAlD
Haloperidol—KCNH2—uterine cervix—vaginal cancer	0.0127	0.0127	CbGeAlD
Haloperidol—HTR2B—female reproductive system—vaginal cancer	0.0119	0.0119	CbGeAlD
Haloperidol—KCNH2—urethra—vaginal cancer	0.0117	0.0117	CbGeAlD
Haloperidol—KCNH2—endometrium—vaginal cancer	0.0115	0.0115	CbGeAlD
Haloperidol—SIGMAR1—female gonad—vaginal cancer	0.0109	0.0109	CbGeAlD
Haloperidol—CYP1A1—epithelium—vaginal cancer	0.0108	0.0108	CbGeAlD
Haloperidol—SIGMAR1—vagina—vaginal cancer	0.0108	0.0108	CbGeAlD
Haloperidol—HTR2B—vagina—vaginal cancer	0.0108	0.0108	CbGeAlD
Haloperidol—CYP1A1—uterine cervix—vaginal cancer	0.0107	0.0107	CbGeAlD
Haloperidol—KCNH2—uterus—vaginal cancer	0.0106	0.0106	CbGeAlD
Haloperidol—CYP3A5—uterine cervix—vaginal cancer	0.0105	0.0105	CbGeAlD
Haloperidol—HRH1—epithelium—vaginal cancer	0.0103	0.0103	CbGeAlD
Haloperidol—HRH1—uterine cervix—vaginal cancer	0.0102	0.0102	CbGeAlD
Haloperidol—CYP1A1—urethra—vaginal cancer	0.00984	0.00984	CbGeAlD
Haloperidol—KCNH2—female reproductive system—vaginal cancer	0.0095	0.0095	CbGeAlD
Haloperidol—CYP1A1—mammalian vulva—vaginal cancer	0.00937	0.00937	CbGeAlD
Haloperidol—HRH1—urethra—vaginal cancer	0.00934	0.00934	CbGeAlD
Haloperidol—HRH1—endometrium—vaginal cancer	0.00919	0.00919	CbGeAlD
Haloperidol—CYP2C19—vagina—vaginal cancer	0.00901	0.00901	CbGeAlD
Haloperidol—CYP1A1—uterus—vaginal cancer	0.00892	0.00892	CbGeAlD
Haloperidol—HRH1—mammalian vulva—vaginal cancer	0.00889	0.00889	CbGeAlD
Haloperidol—KCNH2—female gonad—vaginal cancer	0.00864	0.00864	CbGeAlD
Haloperidol—KCNH2—vagina—vaginal cancer	0.00859	0.00859	CbGeAlD
Haloperidol—HTR2A—epithelium—vaginal cancer	0.00856	0.00856	CbGeAlD
Haloperidol—CYP1A1—female reproductive system—vaginal cancer	0.00802	0.00802	CbGeAlD
Haloperidol—CYP2C9—female reproductive system—vaginal cancer	0.00772	0.00772	CbGeAlD
Haloperidol—HRH1—female reproductive system—vaginal cancer	0.00761	0.00761	CbGeAlD
Haloperidol—CYP1A1—female gonad—vaginal cancer	0.0073	0.0073	CbGeAlD
Haloperidol—CYP1A1—vagina—vaginal cancer	0.00726	0.00726	CbGeAlD
Haloperidol—CYP3A5—female gonad—vaginal cancer	0.00714	0.00714	CbGeAlD
Haloperidol—CYP3A5—vagina—vaginal cancer	0.0071	0.0071	CbGeAlD
Haloperidol—HRH1—female gonad—vaginal cancer	0.00693	0.00693	CbGeAlD
Haloperidol—HRH1—vagina—vaginal cancer	0.00689	0.00689	CbGeAlD
Haloperidol—HTR2A—female reproductive system—vaginal cancer	0.00636	0.00636	CbGeAlD
Haloperidol—CYP3A4—female reproductive system—vaginal cancer	0.00589	0.00589	CbGeAlD
Haloperidol—CYP2D6—female reproductive system—vaginal cancer	0.00579	0.00579	CbGeAlD
Haloperidol—HTR2A—vagina—vaginal cancer	0.00575	0.00575	CbGeAlD
Haloperidol—ABCB1—epithelium—vaginal cancer	0.00561	0.00561	CbGeAlD
Haloperidol—ABCB1—uterine cervix—vaginal cancer	0.00556	0.00556	CbGeAlD
Haloperidol—CYP2D6—female gonad—vaginal cancer	0.00527	0.00527	CbGeAlD
Haloperidol—ABCB1—urethra—vaginal cancer	0.00511	0.00511	CbGeAlD
Haloperidol—ABCB1—endometrium—vaginal cancer	0.00503	0.00503	CbGeAlD
Haloperidol—ABCB1—mammalian vulva—vaginal cancer	0.00487	0.00487	CbGeAlD
Haloperidol—ABCB1—uterus—vaginal cancer	0.00464	0.00464	CbGeAlD
Haloperidol—ABCB1—female reproductive system—vaginal cancer	0.00417	0.00417	CbGeAlD
Haloperidol—ABCB1—female gonad—vaginal cancer	0.00379	0.00379	CbGeAlD
Haloperidol—ABCB1—vagina—vaginal cancer	0.00377	0.00377	CbGeAlD
